625 related articles for article (PubMed ID: 2870177)
1. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
Woodman OL; Vatner SF
J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
[TBL] [Abstract][Full Text] [Related]
2. Nifedipine attenuates both alpha-1 and alpha-2 adrenoceptor-mediated pressor and vasoconstrictor responses in conscious dogs and primates.
Woodman OL; Constantine JW; Vatner SF
J Pharmacol Exp Ther; 1986 Dec; 239(3):648-53. PubMed ID: 3025415
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of nifedipine, nicorandil and nitroglycerin on the pressor responses elicited by selective alpha-1 and alpha-adrenoceptor agonists in conscious dogs.
Wynsen JC; Gross GJ; Brooks HL; Warltier DC
J Pharmacol Exp Ther; 1987 Jun; 241(3):846-54. PubMed ID: 2885410
[TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-adrenoceptor agonists on cardiac output and blood pressure in spinally anesthetized ganglion-blocked dogs.
Yamazaki R; Tsuchida K; Aihara H
Arch Int Pharmacodyn Ther; 1988; 295():80-93. PubMed ID: 2469405
[TBL] [Abstract][Full Text] [Related]
5. Coronary vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptors in conscious dogs.
Woodman OL; Vatner SF
Am J Physiol; 1987 Aug; 253(2 Pt 2):H388-93. PubMed ID: 2887122
[TBL] [Abstract][Full Text] [Related]
6. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
7. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.
Richer C; Lefevre-Borg F; Lechaire J; Gomeni C; Gomeni R; Giudicelli JF; Cavero I
J Pharmacol Exp Ther; 1987 Mar; 240(3):944-53. PubMed ID: 2882016
[TBL] [Abstract][Full Text] [Related]
8. Baroreflex mechanisms buffering alpha-adrenergic agonists in conscious dogs.
Fujii AM; Vatner SF
Am J Physiol; 1987 Oct; 253(4 Pt 2):H728-36. PubMed ID: 2889369
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstriction in the in situ, autoperfused, pulmonary circulation of the anesthetized dog.
Shebuski RJ; Fujita T; Ruffolo RR
J Pharmacol Exp Ther; 1986 Jul; 238(1):217-23. PubMed ID: 3014116
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
Gorczynski RJ; Reynolds RD
J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
[TBL] [Abstract][Full Text] [Related]
11. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
[TBL] [Abstract][Full Text] [Related]
12. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-adrenoceptor blocking properties of the alpha 1-selective agonist 2-(2-chloro-5-trifluoromethylphenylimino)imidazolidine (St 587).
Pichler L; Kobinger W
Arzneimittelforschung; 1985; 35(1A):201-5. PubMed ID: 2859026
[TBL] [Abstract][Full Text] [Related]
14. Factors contributing to blood pressure elevation during norepinephrine and phenylephrine infusions in dogs.
Stokland O; Thorvaldson J; Ilebekk A; Kiil F
Acta Physiol Scand; 1983 Apr; 117(4):481-9. PubMed ID: 6136153
[TBL] [Abstract][Full Text] [Related]
15. The effects of anthopleurin-A on cardiac dynamics in conscious dogs.
Blair RW; Peterson DF; Bishop VS
J Pharmacol Exp Ther; 1978 Nov; 207(2):271-6. PubMed ID: 712617
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
Bass AS; Kohli JD; Lubbers N; Goldberg LI
J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
[TBL] [Abstract][Full Text] [Related]
17. Role of the alpha agonist activity of dobutamine in mediating cardiac output: effects of prolonged isoproterenol infusion.
Hayes JS; Bowling N
J Pharmacol Exp Ther; 1987 Jun; 241(3):861-9. PubMed ID: 2885411
[TBL] [Abstract][Full Text] [Related]
18. Effects of morphine on coronary and left ventricular dynamics in conscious dogs.
Vatner SF; Marsh JD; Swain JA
J Clin Invest; 1975 Feb; 55(2):207-17. PubMed ID: 236324
[TBL] [Abstract][Full Text] [Related]
19. Changes in adrenergic pressor responses by calcium channel modulation in conscious dogs.
Wynsen JC; Gross GJ; Brooks HL; Warltier DC
Am J Physiol; 1987 Sep; 253(3 Pt 2):H531-9. PubMed ID: 2443022
[TBL] [Abstract][Full Text] [Related]
20. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats.
Kawasaki H; Takasaki K
Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):217-33. PubMed ID: 2892472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
